The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia

@article{Byrne2000TheEO,
  title={The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia},
  author={J Byrne and C J Stainer and Gavin Cull and A Haynes and E Bessell and G W Hale and Herman Waldmann and N D Russell},
  journal={Bone Marrow Transplantation},
  year={2000},
  volume={25},
  pages={411-417}
}
unrelated donor (ud) transplantation is the only potentially curative therapy for many leukaemia patients but is associated with a high mortality and morbidity. we sought to identify factors that could be optimised to improve outcome following ud transplantation in adults. data was retrospectively analysed on 55 patients sequentially receiving ud transplants for cml or acute leukaemia (al), all of whom received serotherapy for the prevention of gvhd and rejection. all patients received standard… CONTINUE READING